Manganese is Essential for Neuronal Health

Annual Review of Nutrition

Volumn 35, Issue 1, 2015, Pages 71-108

  Horning, Kyle J ^a   Caito, Samuel W ^b   Tipps, K Grace ^a   Bowman, Aaron B ^a   Aschner, Michael ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Blood brain barrier; Cofactor; Homeostasis; Intracellular trafficking; Metal transport; Neurodevelopment

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ATM PROTEIN; CALCIUM; CHOLINE; CITRIC ACID; DOPAMINE; FERROPORTIN; MANGANESE; METALLOTHIONEIN; PROTEIN P53; SODIUM CALCIUM EXCHANGE PROTEIN; WATER; ZINC TRANSPORTER; ARGINASE; GLUTAMATE AMMONIA LIGASE;

ABSORPTION; ARTIFICIAL MILK; BILIARY EXCRETION; BLOOD BRAIN BARRIER; BRAIN FUNCTION; BRAIN LEVEL; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; DIET; ENVIRONMENTAL FACTOR; EXPOSURE; HUMAN; HUNTINGTON CHOREA; INFLAMMATION; INTRACELLULAR SIGNALING; MILK; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; NUTRITIONAL DEFICIENCY; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; REDOX STRESS; REGULATORY MECHANISM; REVIEW; STORAGE; TRANSPORT KINETICS; BILE; BRAIN; ENZYME ACTIVATION; HEALTH STATUS; HOMEOSTASIS; INTESTINE ABSORPTION; METABOLISM; NERVE CELL;

ARGINASE; BILE; BLOOD-BRAIN BARRIER; BRAIN; ENZYME ACTIVATION; GLUTAMATE-AMMONIA LIGASE; HEALTH STATUS; HOMEOSTASIS; HUMANS; HUNTINGTON DISEASE; INTESTINAL ABSORPTION; MANGANESE; NERVOUS SYSTEM DISEASES; NEURONS; PARKINSON DISEASE;

EID: 84937068083     PISSN: 01999885     EISSN: 15454312     Source Type: Book Series    
DOI: 10.1146/annurev-nutr-071714-034419     Document Type: Review

References (314)

1. Aggarwal A, Vaidya S, Shah S, Singh J, Desai S, Bhatt M. 2006. Reversible Parkinsonism and T1W pallidal hyperintensities in acute liver failure. Mov. Disord. 21:1986-90
2. Ahmed SS, SantoshW. 2010. Metallomic profiling and linkage map analysis of early Parkinson s disease: a new insight to aluminum marker for the possible diagnosis. PLOS ONE 5:e11252
3. Akatsu H, Hori A, Yamamoto T, YoshidaM, Mimuro M, et al. 2012. Transition metal abnormalities in progressive dementias. Biometals 25:337-50
4. Alves G, Thiebot J, Tracqui A, Delangre T, Guedon C, Lerebours E. 1997. Neurologic disorders due to brain manganese deposition in a jaundiced patient receiving long-term parenteral nutrition. J. Parenter. Enteral Nutr. 21:41-45
5. Ambrose M, Goldstine JV, Gatti RA. 2007. Intrinsic mitochondrial dysfunction in ATM-deficient lymphoblastoid cells. Hum. Mol. Genet. 16:2154-64
6. Andersen ME, Gearhart JM, Clewell HJ 3rd. 1999. Pharmacokinetic data needs to support risk assessments for inhaled and ingested manganese. Neurotoxicology 20:161-71
7. Anderson JG, Fordahl SC, Cooney PT, Weaver TL,ColyerCL, EriksonKM. 2008. Manganese exposure alters extracellular GABA, GABA receptor and transporter protein and mRNA levels in the developing rat brain. Neurotoxicology 29:1044-53
8. Andreassen OA, Ferrante RJ, Dedeoglu A, Albers DW, Klivenyi P, et al. 2001. Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP. Exp. Neurol. 167:189-95
9. Antoons G, Mubagwa K, Nevelsteen I, Sipido KR. 2002. Mechanisms underlying the frequency dependence of contraction and [Ca2+]i transients in mouse ventricular myocytes. J. Physiol. 543:889-98
10. Aschner JL, AschnerM. 2005. Nutritional aspects of manganese homeostasis. Mol. Aspects Med. 26:353-62
11. Aschner M, Aschner JL. 1990. Manganese transport across the blood-brain barrier: relationship to iron homeostasis. Brain Res. Bull. 24:857-60
12. Aschner M, Gannon M. 1994. Manganese (Mn) transport across the rat blood-brain barrier: saturable and transferrin-dependent transport mechanisms. Brain Res. Bull. 33:345-49
13. Aschner M, Guilarte TR, Schneider JS, Zheng W. 2007. Manganese: recent advances in understanding its transport and neurotoxicity. Toxicol. Appl. Pharmacol. 221:131-47
14. ATSDR (Agency Toxic Subst. Dis. Regist.). 2008. Toxicological profile for manganese. Atlanta, GA: ATSDR. http://www.atsdr.cdc.gov/toxprofiles/tp.asp?id=102&tid=23
15. Au C, Benedetto A, Anderson J, Labrousse A, Erikson K, et al. 2009. SMF-1, SMF-2 and SMF-3 DMT1 orthologues regulate and are regulated differentially by manganese levels in C. elegans. PLOS ONE 4:e7792
16. Ayton S, Lei P, Duce JA, Wong BXW, Sedjahtera A, et al. 2013. Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease. Ann. Neurol. 73:554-59
17. Bagga P, Patel AB. 2012. Regional cerebral metabolism in mouse under chronic manganese exposure: implications for manganism. Neurochem. Int. 60:177-85
18. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, et al. 1998. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281:1674-77
19. Bassani JW, Bassani RA, Bers DM. 1994. Relaxation in rabbit and rat cardiac cells: species-dependent differences in cellular mechanisms. J. Physiol. 476:279-93
20. Behrens PF, Franz P, Woodman B, Lindenberg KS, Landwehrmeyer GB. 2002. Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. Brain 125:1908-22
21. Bell JG, Keen CL, Lonnerdal B. 1989. Higher retention of manganese in suckling than in adult rats is not due to maturational differences inmanganese uptake by rat small intestine. J. Toxicol. Environ. Health 26:387-98
22. Berkowitz DE, White R, Li D, Minhas KM, Cernetich A, et al. 2003. Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 108:2000-6
23. Bhang SY, Cho SC, Kim JW, Hong YC, Shin MS, et al. 2013. Relationship between blood manganese levels and children s attention, cognition, behavior, and academic performance-A nationwide crosssectional study. Environ. Res. 126:9-16
24. Boaru SG, Merle U, Uerlings R, Zimmermann A,Weiskirchen S, et al. 2014. Simultaneous monitoring of cerebral metal accumulation in an experimentalmodel ofWilson s disease by laser ablation inductively coupled plasma mass spectrometry. BMC Neurosci. 15:98
25. Bornhorst J,Wehe CA, Huwel S, Karst U, Galla HJ, Schwerdtle T. 2012. Impact of manganese on and transfer across blood-brain and blood-cerebrospinal fluid barrier in vitro. J. Biol. Chem. 287:17140-51
26. Bosomworth HJ, Adlard PA, Ford D, Valentine RA. 2013. Altered expression of ZnT10 in Alzheimer s disease brain. PLOS ONE 8:e65475
27. Bowman AB, Aschner M. 2014. Considerations on manganese (Mn) treatments for in vitro studies. Neurotoxicology 41:141-42
28. Bowman AB, Kwakye GF, Herrero Hernandez E, AschnerM. 2011. Role of manganese in neurodegenerative diseases. J. Trace Elements Med. Biol. 25:191-203
29. Braissant O, GotohT, Loup M, Mori M, Bachmann C. 1999. L-arginine uptake, the citrulline-NO cycle and arginase II in the rat brain: an in situ hybridization study. Mol. Brain Res. 70:231-41
30. Britton AA, Cotzias GC. 1966. Dependence of manganese turnover on intake. Am. J. Physiol. 211:203-6
31. Brock AA, Chapman SA, Ulaman EA,Wu G. 1993. Dietary manganese deficiency decreases rat hepatic arginase activity. J. Nutr. 124:340-44
32. Brouillet E. 2014. The 3-NP model of striatal neurodegeneration. Curr. Protoc. Neurosci. 67:9.48.1-14
33. Buettner GR,Ng CF,WangM,Rodgers VGJ, SchaferFQ. 2006.Anew paradigm:manganese superoxide dismutase influences the production of H2O2 in cells and thereby their biological state. Free Radic. Biol. Med. 41:1338-50
34. Burdo JR, Menzies SL, Simpson IA, Garrick LM,Garrick MD, et al. 2001. Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J. Neurosci. Res. 66:1198-207
35. Burkhard PR, Delavelle J, Pasquier RD, Spahr L. 2003. Chronic Parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration. Arch. Neurol. 60:521-28
36. Butterworth J. 1986. Changes in nine enzyme markers for neurons, glia, and endothelial cells in agonal state and Huntington s disease caudate nucleus. J. Neurochem. 47:583-87
37. Cai T, Che H, Yao T, Chen Y, Huang C, et al. 2011. Manganese induces tau hyperphosphorylation through the activation of ERK MAPK pathway in PC12 cells. Toxicol. Sci. 119:169-77
38. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, et al. 1998. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281:1677-79
39. Carmona A, Roudeau S, Perrin L, Veronesi G, Ortega R. 2014. Environmental manganese compounds accumulate as Mn(II) within the Golgi apparatus of dopamine cells: relationship between speciation, subcellular distribution, and cytotoxicity. Metallomics 6:822-32
40. Carter CJ. 1982. Glutamine synthetase activity in Huntington s disease. Life Sci. 31:1151-59
41. Chan DW. 2000. Purification and characterization of ATM from human placenta. A manganesedependent, Wortmannin-sensitive serine/threonine protein kinase. J. Biol. Chem. 275:7803-10
42. Chen J, MarksE,Lai B, ZhangZ,Duce JA, et al. 2013. Iron accumulates in Huntington s disease neurons: protection by deferoxamine. PLOS ONE 8:e77023
43. Chen L, Ding G, Gao Y, Wang P, Shi R, et al. 2014. Manganese concentrations in maternal-infant blood and birth weight. Environ. Sci. Pollut. Res. Int. 21:6170-75
44. ChiangMC, Chen HM, Lai HL, Chen HW, Chou SY, et al. 2009. The A2A adenosine receptor rescues the urea cycle deficiency of Huntington s disease by enhancing the activity of the ubiquitin-proteasome system. Hum. Mol. Genet. 18:2929-42
45. ChiangMC, Chen HM, Lee YH, Chang HH, Wu YC, et al. 2007. Dysregulation of C/EBPαby mutant Huntingtin causes the urea cycle deficiency in Huntington s disease. Hum. Mol. Genet. 16:483-98
46. Chun HS, Lee HH, Son JH. 2001. Manganese induces endoplasmic reticulum (ER) stress and activates multiple caspases in nigral dopaminergic neuronal cells, SN4741. Neurosci. Lett. 316:5-8
47. Cohn JR, Emmett EA. 1978. The excretion of trace metals in human sweat. Ann. Clin. Lab. Sci. 8:270-75
48. Colton CA, Mott RT, Sharpe H, Xu Q, Van Nostrand WE, Vitek MP. 2006. Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J. Neuroinflammation 3:27
49. Cordova FM, Aguiar AS Jr, Peres TV, Lopes MW, Goncalves FM, et al. 2013. Manganese-exposed developing rats display motor deficits and striatal oxidative stress that are reversed by Trolox. Arch. Toxicol. 87:1231-44
50. Cordova FM, Aguiar AS Jr, Peres TV, Lopes MW, Goncalves FM, et al. 2012. In vivo manganese exposure modulates Erk, Akt and Darpp-32 in the striatum of developing rats, and impairs their motor function. PLOS ONE 7:e33057
51. Criswell SR, Perlmutter JS, Huang JL, Golchin N, Flores HP, et al. 2012. Basal ganglia intensity indices and diffusion weighted imaging in manganese-exposed welders. Occup. Environ. Med. 69:437-43
52. Criswell SR, Perlmutter JS, Videen TO, Moerlein SM, Flores HP, et al. 2011. Reduced uptake of [18F]FDOPA PET in asymptomatic welders with occupational manganese exposure. Neurology 76:1296-301
53. Crittenden PL,FilipovNM.2008. Manganese-induced potentiation of in vitro proinflammatory cytokine production by activated microglial cells is associated with persistent activation of p38 MAPK. Toxicol. In Vitro 22:18-27
54. Crittenden PL, Filipov NM. 2011. Manganese modulation of MAPK pathways: effects on upstream mitogen activated protein kinase kinases and mitogen activated kinase phosphatase-1 in microglial cells. J. Appl. Toxicol. 31:1-10
55. Crossgrove J, ZhengW. 2004. Manganese toxicity upon overexposure. NMR Biomed. 17:544-53
56. Crossgrove JS, Allen DD, Bukaveckas BL, Rhineheimer SS, Yokel RA. 2003. Manganese distribution across the blood-brain barrier I. Evidence for carrier-mediated influx of manganese citrate as well as manganese and manganese transferrin. Neurotoxicology 24:3-13
57. Crossgrove JS, Yokel RA. 2004. Manganese distribution across the blood-brain barrier. III. The divalent metal transporter-1 is not the major mechanism mediating brain manganese uptake. Neurotoxicology 25:451-60
58. Crossgrove JS, Yokel RA. 2005. Manganese distribution across the blood-brain barrier. IV. Evidence for brain influx through store-operated calcium channels. Neurotoxicology 26:297-307
59. Czlonkowska A, Kohutnicka M, Kurkowska-Jastrzebska I, Czlonkowski A. 1996. Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson s disease mice model. Neurodegeneration 5:137-43
60. D Antonio EL, Hai Y, Christianson DW. 2012. Structure and function of non-native metal clusters in human arginase I. Biochemistry 51:8399-409
61. Das A Jr, Hammad TA. 2000. Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis. Osteoarthritis Cartilage 8:343-50
62. DavidssonL,Cederblad A, Lonnerdal B, Sandstrom B. 1991. The effect of individual dietary components on manganese absorption in humans. Am. J. Clin. Nutr. 54:1065-70
63. Davidsson L, Cederblad A, Lonnerdal B, Sandstrom B. 1989. Manganese absorption from human milk, cow s milk, and infant formulas in humans. Am. J. Dis. Child. 143:823-27
64. Davidsson L, Loennerdal B, Sandstroem B, Kunz C, Keen CL. 1989. Identification of transferrin as the major plasma carrier protein for manganese introduced orally or intravenously or after in vitro addition in the rat. J. Nutr. 119:1461-64
65. Davidsson LA, Lonnerdal B. 1989. Fe-saturation and proteolysis of human lactoferrin: effect on brushborder receptor-mediated uptake of Fe and Mn. Am. J. Physiol. 257:G930-34
66. Davis CD, Greger JL. 1992. Longitudinal changes of manganese-dependent superoxide dismutase and other indexes of manganese and iron status in women. Am. J. Clin. Nutr. 55:747-52
67. Davis CD, Zech L, Greger JL. 1993. Manganese metabolism in rats: an improved methodology for assessing gut endogenous losses. Proc. Soc. Exp. Biol. Med. 202:103-8
68. Deckel AW, Tang V, Nuttal D, Gary KA, Elder R. 2002. Altered neuronal nitric oxide synthase expression contributes to disease progression in Huntington s disease transgenic mice. Brain Res. 939:76-86
69. Deckel AW, Volmer P, Weiner R, Gary KA, Covault J, et al. 2000. Dietary arginine alters time of symptom onset in Huntington s disease transgenic mice. Brain Res. 875:187-95
70. Delnooz CC, Wevers RA, Quadri M, Clayton PT, Mills PB, et al. 2013. Phenotypic variability in a dystonia family with mutations in the manganese transporter gene. Mov. Disord. 28:685-86
71. Deng K, He H, Qiu J, Lorber B, Bryson JB, Filbin MT. 2009. Increased synthesis of spermidine as a result of upregulation of arginase I promotes axonal regeneration in culture and in vivo. J. Neurosci. 29:9545-52
72. Dickinson TK, Devenyi AG, Connor JR. 1996. Distribution of injected ion 59 and manganese 54 in hypotransferrinemic mice. J. Lab. Clin. Med. 128:270-78
73. Dode L, Andersen JP, Raeymaekers L, Missiaen L, Vilsen B, Wuytack F. 2005. Functional comparison between secretory pathway Ca2+/Mn2+-ATPase (SPCA) 1 and sarcoplasmic reticulum Ca2+-ATPase (SERCA) 1 isoforms by steady-state and transient kinetic analyses. J. Biol. Chem. 280:39124-34
74. Dode L, Andersen JP, Vanoevelen J, Raeymaekers L,Missiaen L, et al. 2006. Dissection of the functional differences between human secretory pathway Ca2+/Mn2+-ATPase (SPCA) 1 and 2 isoenzymes by steady-state and transient kinetic analyses. J. Biol. Chem. 281:3182-89
75. Doker S,Mounicou S,DoganM, Lobinski R. 2010. Probing themetal-homeostatis effects of the administration of chromium(VI) to mice by ICPMS and size-exclusion chromatography-ICP MS. Metallomics 2:549-55
76. Dorman DC, Struve MF, Clewell HJ 3rd, Andersen ME. 2006. Application of pharmacokinetic data to the risk assessment of inhaled manganese. Neurotoxicology 27:752-64
77. Dorman DC, StruveMF, James RA, McManus BE, Marshall MW,Wong BA. 2001. Influence of dietary manganese on the pharmacokinetics of inhaledmanganese sulfate inmaleCDrats. Toxicol. Sci. 60:242-51
78. dos Santos AP, Milatovic D, Au C, Yin Z, Batoreu MC, Aschner M. 2010. Rat brain endothelial cells are a target of manganese toxicity. Brain Res. 1326:152-61
79. Dumont M, Wille E, Stack C, Calingasan NY, Beal MF, Lin MT. 2009. Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer s disease. FASEB J. 23:2459-66
80. Dydak U, Jiang YM, Long LL, Zhu H, Chen J, et al. 2011. In vivo measurement of brain GABA concentrations by magnetic resonance spectroscopy in smelters occupationally exposed to manganese. Environ. Health Perspect. 119:219-24
81. Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, et al. 2006. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ. Health Perspect. 114:1172-78
82. Ensunsa JL, Symons JD, Lanoue L, Schrader HR, Keen CL. 2004. Reducing arginase activity via dietary manganese deficiency enhances endothelium-dependent vasorelaxation of rat aorta. Exp. Biol. Med. 229:1143-53
83. Ergen K, Ince H, Duzova H, Karakoc Y, Emre MH. 2013. Acute effects of moderate and strenuous running on trace element distribution in the brain, liver, and spleen of trained rats. Balkan Med. J. 30:105-10
84. EriksonK, AschnerM. 2002. Manganese causes differential regulation of glutamate transporter (GLAST) taurine transporter and metallothionein in cultured rat astrocytes. Neurotoxicology 23:595-602
85. Erikson KM, Suber RL, Aschner M. 2002. Glutamate/aspartate transporter (GLAST), taurine transporter and metallothionein mRNA levels are differentially altered in astrocytes exposed to manganese chloride, manganese phosphate or manganese sulfate. Neurotoxicology 23:281-88
86. Esch F, Lin K, Hills A, Baraban JM, Chatterjee S, et al. 1998. Purification of a multipotent antideath activity from bovine liver and its identification as arginase: nitric oxide-independent inhibition of neuronal apoptosis. J. Neurosci. 18:4083-95
87. Estevez AG, Sahawneh MA, Lange PS, Bae N, EgeaM, Ratan RR. 2006. Arginase 1 regulation of nitric oxide production is key to survival of trophic factor-deprived motor neurons. J. Neurosci. 26:8512-16
88. Eum JH, Cheong HK, Ha EH, Ha M, Kim Y, et al. 2014. Maternal blood manganese level and birth weight: a MOCEH birth cohort study. Environ. Health 13:31
89. Fallon EM, Le HD, Puder M. 2010. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil. Curr. Opin. Organ Transplant. 15:334-40
90. Ferlazzo ML, Sonzogni L, Granzotto A, Bodgi L, Lartin O, et al. 2014. Mutations of the Huntington s disease protein impact on the ATM-dependent signaling and repair pathways of the radiation-induced DNA double-strand breaks: corrective effect of statins and bisphosphonates. Mol. Neurobiol. 49:1200-11
91. Filipov NM, Seegal RF, Lawrence DA. 2005. Manganese potentiates in vitro production of proinflammatory cytokines and nitric oxide by microglia through a nuclear factor kappa B-dependent mechanism. Toxicol. Sci. 84:139-48
92. Finkelstein Y, Zhang N, Fitsanakis VA, Avison MJ, Gore JC, Aschner M. 2008. Differential deposition of manganese in the rat brain following subchronic exposure to manganese: a T1-weighted magnetic resonance imaging study. Israel Med. Assoc. J. 10:793-98
93. Finley JW, Johnson PE, Johnson LK. 1994. Sex affects manganese absorption and retention by humans from a diet adequate in manganese. Am. J. Clin. Nutr. 60:949-55
94. Fitsanakis VA, Piccola G, Aschner JL, AschnerM. 2006. Characteristics of manganese (Mn) transport in rat brain endothelial (RBE4) cells, an in vitro model of the blood-brain barrier. Neurotoxicology 27:60-70
95. Fitsanakis VA, Piccola G, Aschner JL, Aschner M. 2005. Manganese transport by rat brain endothelial (RBE4) cell-based Transwell model in the presence of astrocyte conditioned media. J. Neurosci. Res. 81:235-43
96. Fitsanakis VA, Zhang N, Anderson JG, Erikson KM, Avison MJ, et al. 2008. Measuring brain manganese and iron accumulation in rats following 14 weeks of low-dose manganese treatment using atomic absorption spectroscopy and magnetic resonance imaging. Toxicol. Sci. 103:116-24
97. Fitsanakis VA, Zhang N, Avison MJ, Erikson KM, Gore JC, Aschner M. 2011. Changes in dietary iron exacerbate regional brain manganese accumulation as determined by magnetic resonance imaging. Toxicol. Sci. 120:146-53
98. FlemingMD, Romano MA, SuMA, Garrick LM, Garrick MD, Andrews NC. 1998. Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. PNAS 95:1148-53
99. Foradori AC, Bertinchamps A, Gulibon JM, Cotzias GC. 1967. The discrimination between magnesium and manganese by serum proteins. J. Gen. Physiol. 50:2255-66
100. Forbes JR, Gros P. 2003. Iron, manganese, and cobalt transport by Nramp1 (Slc11a1) and Nramp2 (Slc11a2) expressed at the plasma membrane. Blood 102:1884-92
101. Fordahl SC, Anderson JG, Cooney PT, Weaver TL, Colyer CL, Erikson KM. 2010. Manganese exposure inhibits the clearance of extracellular GABA and influences taurine homeostasis in the striatum of developing rats. Neurotoxicology 31:639-46
102. Frankel D. 1993. Supplementation of trace elements in parenteral nutrition: rationale and recommendations. Nutr. Res. 13:583-96
103. Friedman BJ, Freeland-Graves JH, BalesCW, Behmardi F, Shorey-Kutschke RL, et al. 1987. Manganese balance and clinical observations in young men fed a manganese-deficient diet. J. Nutr. 117:133-43
104. Fujishiro H, Ohashi T, Takuma M, Himeno S. 2013. Suppression of ZIP8 expression is a common feature of cadmium-resistant and manganese-resistant RBL-2H3 cells. Metallomics 5:437-44
105. Fujishiro H, Yoshida M, Nakano Y, Himeno S. 2014. Interleukin-6 enhances manganese accumulation in SH-SY5Y cells: implications of the up-regulation of ZIP14 and the down-regulation of ZnT10. Metallomics 6:944-49
106. Garcia-Aranda JA, Wapnir RA, Lifshitz F. 1983. In vivo intestinal absorption of manganese in the rat. J. Nutr. 113:2601-7
107. Garcia SJ, Gellein K, Syversen T, Aschner M. 2007. Iron deficient and manganese supplemented diets alter metals and transporters in the developing rat brain. Toxicol. Sci. 95:205-14
108. Garrick MD,Dolan KG,Hobinski C, Ghio AJ, Higgins D, et al. 2003. DMT1: a mammalian transporter for multiple metals. Biometals 16:41-54
109. Gavin CE, Gunter KK, Gunter TE. 1990. Manganese and calcium efflux kinetics in brain mitochondria. Biochem. J. 266:329-34
110. Gitler AD, Chesi A, Geddie ML, Strathearn KE, Hamamichi S, et al. 2009. Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat. Genet. 41:308-15
111. Gorovitz RA, Avisar N, Shaked I, Vardimon L. 1997. Glutamine synthetase protects against neuronal degeneration in injured retinal tissue. PNAS 94:7024-29
112. Goytain A, Hines RM, Quamme GA. 2008. Huntingtin-interacting proteins, HIP14 and HIP14L, mediate dual functions, palmitoyl acyltransferase and Mg2+ transport. J. Biol. Chem. 283:33365-74
113. Graham MF, Tavill AS, Halpin TC, Louis LN. 1984. Inhibition of bile flow in the isolated perfused rat liver by a synthetic parenteral amino acid mixture: associated net amino acid fluxes. Hepatology 4:69-73
114. Greger JL. 1998. Dietary standards formanganese: overlap between nutritional and toxicological studies. J. Nutr. 128:368-71S
115. Grimm C, Kraft R, Sauerbruch S, Schultz G, Harteneck C. 2003. Molecular and functional characterization of the melastatin-related cation channel TRPM3. J. Biol. Chem. 278:21493-501
116. Gruenheid S, Canonne-Hergaux F, Gauthier S, Hackam DJ, Grinstein S, Gros P. 1999. The iron transport protein NRAMP2 is an integral membrane glycoprotein that colocalizes with transferrin in recycling endosomes. J. Exp. Med. 189:831-41
117. Guilarte TR. 2010. APLP1, Alzheimer s-like pathology and neurodegeneration in the frontal cortex of manganese-exposed non-human primates. Neurotoxicology 31:572-74
118. Guilarte TR, Burton NC, Verina T, Prabhu VV, Becker KG, et al. 2008. Increased APLP1 expression and neurodegeneration in the frontal cortex of manganese-exposed non-human primates. J. Neurochem. 105:1948-59
119. Guilarte TR, Chen MK, McGlothan JL, Verina T, Wong DF, et al. 2006. Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates. Exp. Neurol. 202:381-90
120. Guilbert A,Gautier M, Dhennin-Duthille I, HarenN, SevestreH,Ouadid-AhidouchH. 2009. Evidence that TRPM7 is required for breast cancer cell proliferation. Am. J. Physiol. Cell Physiol. 297:C493-502
121. GunshinH,Mackenzie B, Berger UV,Gunshin Y, Romero MF, et al. 1997. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 338:482-88
122. Gunter TE,Gavin CE, AschnerM,Gunter KK. 2006. Speciation ofmanganese in cells andmitochondria: a search for the proximal cause of manganese neurotoxicity. Neurotoxicology 27:765-76
123. Gunter TE, Gerstner B, Gunter KK, Malecki J, Gelein R, et al. 2013. Manganese transport via the transferrin mechanism. Neurotoxicology 34:118-27
124. Gunteski Hamblin AM, Clarke DM, Shull GE. 1992. Molecular cloning and tissue distribution of alternatively spliced mRNAs encoding possible mammalian homologues of the yeast secretory pathway calcium pump. Biochemistry 31:7600-8
125. Guo ZK, Kozlov S, Lavin MF, PersonMD, Paull TT. 2010. ATM activation by oxidative stress. Science 330:517-21
126. Hansen SL, Trakooljul N, Liu HC, Moeser AJ, Spears JW. 2009. Iron transporters are differentially regulated by dietary iron, and modifications are associated with changes in manganese metabolism in young pigs. J. Nutr. 139:1474-79
127. Hare DJ, George JL, Grimm R, Wilkins S, Adlard PA, et al. 2010. Three-dimensional elemental bioimaging of Fe, Zn, Cu, Mn and P in a 6-hydroxydopamine lesioned mouse brain. Metallomics 2:745-53
128. HarrisWR, Chen Y. 1994. Electron paramagnetic resonance and difference ultraviolet studies of Mn2+ binding to serumtransferrin. J. Inorg. Biochem. 54:1-19
129. Hassel B, Bachelard H, Jones P, Fonnum F, Sonnewald U. 1997. Trafficking of amino acids between neurons and glia in vivo. Effects of inhibition of glial metabolism by fluoroacetate. J. Cereb. Blood Flow Metab. 17:1230-38
130. He L, Girijashanker K, Dalton TP, Reed J, Li H, et al. 2006. ZIP8, member of the solute-carrier-39 (SLC39) metal-transporter family: characterization of transporter properties. Mol. Pharmacol. 70:171-80
131. Herrero Hernandez E, Discalzi G, Valentini C, Venturi F, Chio A, et al. 2006. Follow-up of patients affected by manganese-induced Parkinsonism after treatment with CaNa2EDTA. Neurotoxicology 27:333-39
132. Hertz LY, Yu A, Svenneby G, Kvamme E, Fosmark H, Schousboe A. 1980. Absence of preferential glutamine uptake into neurons-an indication of a net transfer of TCA constituents from nerve endings to astrocytes? Neurosci. Lett. 16:103-9
133. Higashi Y, Asanuma M, Miyazaki I,Hattori N, Mizuno Y, OgawaN. 2004. Parkin attenuates manganeseinduced dopaminergic cell death. J. Neurochem. 89:1490-97
134. Hirata Y, Furuta K, Miyazaki S, Suzuki M, Kiuchi K. 2004. Anti-apoptotic and pro-apoptotic effect of NEPP11 on manganese-induced apoptosis and JNK pathway activation in PC12 cells. Brain Res. 1021:241-47
135. Hopfner K, Karcher A, Craig L, Woo TT, Carney JP, Tainer JA. 2001. Structural biochemistry and interaction architecture of the DNA double-strand break repair Mre11 nuclease and Rad50-ATPase. Cell 105:473-85
136. Hozumi I, Hasegawa T, Honda A, Ozawa K, Hayashi Y, et al. 2011. Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. J. Neurol. Sci. 303:95-99
137. Huang E, Ong WY, Connor JR. 2004. Distribution of divalent metal transporter-1 in the monkey basal ganglia. Neuroscience 128:487-96
138. HuangK, Sanders SS, Kang R, Carroll JB, SuttonL, et al. 2011. Wild-typeHTTmodulates the enzymatic activity of the neuronal palmitoyl transferase HIP14. Hum. Mol. Genet. 20:3356-65
139. HuangK,Yanai A, Kang R, Arstikaitis P, Singaraja RR, et al. 2004. Huntingtin-interacting protein HIP14 is a palmitoyl transferase involved in palmitoylation and trafficking of multiple neuronal proteins. Neuron 44:977-86
140. Iinuma Y, Kubota M, Uchiyama M, Yagi M, Kanada S, et al. 2003. Whole-blood manganese levels and brain manganese accumulation in children receiving long-term home parenteral nutrition. Pediatr. Surg. Int. 19:268-72
141. Jursa T, Smith DR. 2009. Ceruloplasmin alters the tissue disposition and neurotoxicity of manganese, but not its loading onto transferrin. Toxicol. Sci. 107:182-93
142. Kalia K, Jiang W, Zheng W. 2008. Manganese accumulates primarily in nuclei of cultured brain cells. Neurotoxicology 29:466-70
143. Kannurpatti SS, Joshi PG, Joshi NB. 2000. Calcium sequestering ability of mitochondria modulates influx of calcium through glutamate receptor channel. Neurochem. Res. 25:1527-36
144. Kanyo ZF, Scolnick LR, Ash DE, Christianson DW. 1996. Structure of a unique binuclear manganese cluster in arginase. Nature 383:554-57
145. Keefer RC, Barak AJ, Boyett JD. 1970. Binding of manganese and transferrin in rat serum. Biochim. Biophys. Acta 221:390-93
146. Keen CL, Bell JG, Lonnerdal B. 1986. The effect of age on manganese uptake and retention from milk and infant formulas in rats. J. Nutr. 116:395-402
147. Keen CL,Ensunsa JL,WatsonMH, Baly DL,Donovan SM, et al. 1999. Nutritional aspects of manganese from experimental studies. Neurotoxicology 20:213-23
148. Keller JN, Kindy MS, Holtsberg FW, St Clair DK, Yen HC, et al. 1998. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J. Neurosci. 18:687-97
149. Kobayashi K, Kuroda J, Shibata N, Hasegawa T, Seko Y, et al. 2007. Induction of metallothionein by manganese is completely dependent on interleukin-6 production. J. Pharmacol. Exp. Ther. 320:721-27
150. Kong SM, Chan BK, Park JS, Hill KJ, Aitken JB, et al. 2014. Parkinson s disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes. Hum. Mol. Genet. 23:2816-33
151. Kozlov S. 2003. ATP activates ataxia-telangiectasia mutated (ATM) in vitro. Importance of autophosphorylation. J. Biol. Chem. 278:9309-17
152. Krishna S, Dodd CA, Hekmatyar SK, Filipov NM. 2014. Brain deposition and neurotoxicity of manganese in adult mice exposed via the drinking water. Arch. Toxicol. 88:47-64
153. Kulijewicz-NawrotM, SykovaE,Chvatal A, VerkhratskyA,Rodriguez JJ. 2013. Astrocytes and glutamate homoeostasis in Alzheimer s disease: a decrease in glutamine synthetase, but not in glutamate transporter-1, in the prefrontal cortex. ASN Neuro 5:273-82
154. Kumar KK, Lowe EW Jr, Aboud AA, Neely MD, Redha R, et al. 2014. Cellular manganese content is developmentally regulated in human dopaminergic neurons. Sci. Rep. 4:6801
155. Kuo HS, Tsai MJ, Huang MC, Chiu CW, Tsai CY, et al. 2011. Acid fibroblast growth factor and peripheral nerve grafts regulate Th2 cytokine expression, macrophage activation, polyamine synthesis, and neurotrophin expression in transected rat spinal cords. J. Neurosci. 31:4137-47
156. Lawson LJ, Perry VH, Dri P, Gordon S. 1990. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39:151-70
157. Leblondel G, Allain P. 1999. Manganese transport by Caco-2 cells. Biol. Trace Element Res. 67:13-28
158. Lebovitz RM, ZhangH, VogelH, Cartwright JJ, Dionne L, et al. 1996. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. PNAS 93:9782-87
159. LechpammerM, Clegg MS,Muzar Z, Huebner PA, Jin LW, Gospe SMJr. 2014. Pathology of inherited manganese transporter deficiency. Ann. Neurol. 75:608-12
160. Lee J, Ryu H, Ferrante RJ, Morris SMJr, Ratan RR. 2003. Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox. PNAS 100:4843-48
161. Leffler CT, Philippi AF, Leffler SG, Mosure JC, Kim PD. 1999. Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study. Mil. Med. 164:85-91
162. Leggett RW. 2011. A biokinetic model for manganese. Sci. Total Environ. 409:4179-86
163. Lehmann C, Bette S, Engele J. 2009. High extracellular glutamate modulates expression of glutamate transporters and glutamine synthetase in cultured astrocytes. Brain Res. 1297:1-8
164. Leitch S, Feng M, Muend S, Braiterman LT, Hubbard AL, Rao R. 2011. Vesicular distribution of secretory pathway Ca2+-ATPase isoform 1 and a role in manganese detoxification in liver-derived polarized cells. Biometals 24:159-70
165. Leyva-Illades D, Chen P, Zogzas CE,Hutchens S,Mercado JM, et al. 2014. SLC30A10 is a cell surfacelocalized manganese efflux transporter, and Parkinsonism-causing mutations block its intracellular trafficking and efflux activity. J. Neurosci. 34:14079-95
166. Li DW, Liu JP, Schmid PC, Schlosser R, Feng H, et al. 2006. Protein serine/threonine phosphatase-1 dephosphorylates p53 at Ser-15 and Ser-37 to modulate its transcriptional and apoptotic activities. Oncogene 25:3006-22
167. Li X, Xie J, Lu L, Zhang L, Zhang L, et al. 2013. Kinetics of manganese transport and gene expressions of manganese transport carriers in Caco-2 cell monolayers. Biometals 26:941-53
168. Liccione JJ, Maines MD. 1988. Selective vulnerability of glutathione metabolism and cellular defense mechanisms in rat striatum to manganese. J. Pharmacol. Exp. Ther. 247:156-61
169. LimboO,MoianiD, Kertokalio A, Wyman C, Tainer JA, Russell P. 2012. Mre11 ATLD17/18 mutation retains Tel1/ATM activity but blocks DNA double-strand break repair. Nucleic Acids Res. 40:11435-49
170. Liu M, Cai T, Zhao F, Zheng G, Wang Q, et al. 2009. Effect of microglia activation on dopaminergic neuronal injury induced by manganese, and its possible mechanism. Neurotox. Res. 16:42-49
171. Ljung K, Palm B, Grander M, Vahter M. 2011. High concentrations of essential and toxic elements in infant formula and infant foods-A matter of concern. Food Chem. 127:943-51
172. Lockman PR, Roder KE, Allen DD. 2001. Inhibition of the rat blood brain barrier choline transporter by manganese chloride. J. Neurochem. 79:588-94
173. Lonnerdal B. 1994. Nutritional aspects of soy formula. Acta Paediatr. Suppl. 402:105-8
174. Loranger S, Zayed J. 1997. Environmental contamination and human exposure to airborne total and respirable manganese in Montreal. J. Air Waste Manag. Assoc. 47:983-89
175. Loutzenhiser K, Loutzenhiser R. 2000. Angiotensin II-induced Ca2+ influx in renal afferent and efferent arterioles differing roles of voltage gated and store operated Ca2+ entry. Circ. Res. 87:551-57
176. Lucaciu CM, Dragu C, Copəescu L, Morariu VV. 1997. Manganese transport through human erythrocyte membranes. An EPR study. Biochim. Biophys. Acta 1328:90-98
177. Madejczyk MS, Ballatori N. 2012. The iron transporter ferroportin can also function as a manganese exporter. Biochim. Biophys. Acta 1818:651-57
178. Madison JL, Wegrzynowicz M, Aschner M, Bowman AB. 2012. Disease-toxicant interactions in manganese exposed Huntington disease mice: early changes in striatal neuron morphology and dopamine metabolism. PLOS ONE 7:e31024
179. Marion S, Urs NM, Peterson SM, Sotnikova TD, Beaulieu JM, et al. 2014. Dopamine D2 receptor relies upon PPM/PP2C protein phosphatases to dephosphorylate huntingtin protein. J. Biol. Chem. 289:11715-24
180. Masuda M, Braun-Sommargren M, Crooks D, Smith DR. 2013. Golgi phosphoprotein 4 (GPP130) is a sensitive and selective cellular target of manganese exposure. Synapse 67:205-15
181. McCarthy RC, Kosman DJ. 2012. Mechanistic analysis of iron accumulation by endothelial cells of the BBB. Biometals 25:665-75
182. McDougall SA, Der-Ghazarian T, Britt CE, Varela FA, Crawford CA. 2011. Postnatal manganese exposure alters the expression of D2L and D2S receptor isoforms: relationship to PKA activity and Akt levels. Synapse 65:583-91
183. Institute ofMedicine. 2001. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: Natl. Acad. Press
184. Micaroni M, Perinetti G, Berrie CP, Mironov AA. 2010. The SPCA1 Ca2+ pump and intracellular membrane trafficking. Traffic 11:1315-33
185. Michalke B, Berthele A,Mistriotis P,Ochsenkuhn-Petropoulou M, Halbach S. 2007. Manganese species from human serum, cerebrospinal fluid analyzed by size exclusion chromatography-, capillary electrophoresis coupled to inductively coupled plasma mass spectrometry. J. Trace Elem. Med. Biol. 21(Suppl. 1):4-9
186. Midvan AS, ScruttonMC, UtterMF. 1966. Pyruvate carboxylase: VII. A possible role for tightly bound manganese. J. Biol. Chem. 241:3488-98
187. Milatovic D, Yin Z, Gupta RC, Sidoryk M, Albrecht J, et al. 2007. Manganese induces oxidative impairment in cultured rat astrocytes. Toxicol. Sci. 98:198-205
188. Mishra G, Shukla R, Hasan M, Khanna SK, Das M. 2009. Potentiation of neurotoxicity of Lathyrus sativus by manganese: alterations in blood-brain barrier permeability. Toxicol. Mech. Methods 19:318-26
189. Missiaen L, Raeymaekers L, Dode L, Vanoevelen J, Van Baelen K, et al. 2004. SPCA1 pumps and Hailey-Hailey disease. Biochem. Biophys. Res. Commun. 322:1204-13
190. Mitchell CJ, Shawki A, Ganz T, Nemeth E, Mackenzie B. 2014. Functional properties of human ferroportin, a cellular iron exporter reactive also with cobalt and zinc.Am. J. Physiol. Cell Physiol. 306:C450-59
191. Mizuno K, Whittaker MM, Bachinger HP, Whittaker JW. 2004. Calorimetric studies on the tight binding metal interactions of Escherichia coli manganese superoxide dismutase. J. Biol. Chem. 279:27339-44
192. Moberly AH, Czarnecki LA, Pottackal J, Rubinstein T, Turkel DJ, et al. 2012. Intranasal exposure to manganese disrupts neurotransmitter release from glutamatergic synapses in the central nervous system in vivo. Neurotoxicology 33:996-1004
193. Mochel F, DeLonlay P, Touati G, Brunengraber H, Kinman RP, et al. 2005. Pyruvate carboxylase deficiency: clinical and biochemical response to anaplerotic diet therapy. Mol. Genet. Metab. 84:305-12
194. Morello M, Canini A, Mattioli P, Sorge RP, Alimonti A, et al. 2008. Sub-cellular localization of manganese in the basal ganglia of normal and manganese-treated rats: an electron spectroscopy imaging and electron energy-loss spectroscopy study. Neurotoxicology 29:60-72
195. Morello M, Zatta P, Zambenedetti P, Martorana A, D Angelo V, et al. 2007. Manganese intoxication decreases the expression of manganoproteins in the rat basal ganglia: an immunohistochemical study. Brain Res. Bull. 74:406-15
196. Mukhopadhyay S, Bachert C, Smith DR, Linstedt AD. 2010. Manganese-induced trafficking and turnover of the cis-Golgi glycoprotein GPP130. Mol. Biol. Cell 21:1282-92
197. Mukhopadhyay S, Linstedt AD. 2011. Identification of a gain-of-function mutation in a Golgi P-type ATPase that enhances Mn2+ efflux and protects against toxicity. PNAS 108:858-63
198. Murin R, Verleysdonk S, Raeymaekers L, Kaplan P, Lehotsky J. 2006. Distribution of secretory pathway Ca2+ ATPase (SPCA1) in neuronal and glial cell cultures. Cell. Mol. Neurobiol. 26:1355-65
199. Napolitano M, Centonze D, Gubellini P, Rossi S, Spiezia S, et al. 2004. Inhibition of mitochondrial complex II alters striatal expression of genes involved in glutamatergic and dopaminergic signaling: possible implications for Huntington s disease. Neurobiol. Dis. 15:407-14
200. Nischwitz V, Berthele A, Michalke B. 2008. Speciation analysis of selected metals and determination of their total contents in paired serum and cerebrospinal fluid samples: an approach to investigate the permeability of the human blood-cerebrospinal fluid-barrier. Anal. Chim. Acta 627:258-69
201. NooneML, Kumar P, Ummer K, Achambat L, Salam KA. 2008. Cirrhosis presenting as Parkinsonism. Ann. Indian Acad. Neurol. 11:179-81
202. Norenberg MD. 1979. Distribution of glutamine synthetase in the rat central nervous system. J. Histochem. Cytochem. 27:756-62
203. Ohyama T, Verstreken P, Ly CV, Rosenmund T, Rajan A, et al. 2007. Huntingtin-interacting protein 14, a palmitoyl transferase required for exocytosis and targeting of CSP to synaptic vesicles. J. Cell Biol. 179:1481-96
204. Okunade GW, Miller ML, Azhar M, Andringa A, Sanford LP, et al. 2007. Loss of the Atp2c1 secretory pathway Ca2+-ATPase (SPCA1) in mice causes Golgi stress, apoptosis, and midgestational death in homozygous embryos and squamous cell tumors in adult heterozygotes. J. Biol. Chem. 282:26517-27
205. Olabarria M, Noristani HN, Verkhratsky A, Rodriguez JJ. 2011. Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer s disease mouse model: mechanism for deficient glutamatergic transmission? Mol. Neurodegener. 6:55
206. Olanow CW, Good PF, Shinotoh H, Hewitt KA, Vingerhoets F, et al. 1996. Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study. Neurology 46:492-98
207. Parenti M, Rusconi L, Cappabianca V, Parati EA, Groppetti A. 1988. Role of dopamine in manganese neurotoxicity. Brain Res. 473:236-40
208. Paull TT, Gellert M. 1998. The 3- to 5- exonuclease activity ofMre11 facilitates repair of DNA doublestrand breaks. Mol. Cell 1:969-79
209. Pellizzari ED, Clayton CA, Rodes CE, Mason RE, Piper LL, et al. 2001. Particulate matter and manganese exposures in Indianapolis, Indiana. J. Expo. Anal. Environ. Epidemiol. 11:423-40
210. Pellizzari ED, Clayton CA, Rodes CE, Mason RE, Piper LL, et al. 1999. Particulate matter and manganese exposures in Toronto, Canada. Atmos. Environ. 33:721-34
211. Penland JG, Johnson PE. 1993. Dietary calcium and manganese effects on menstrual cycle symptoms. Am. J. Obstet. Gynecol. 168:1417-23
212. Prabhakaran K, Ghosh D, Chapman GD, Gunasekar PG. 2008. Molecular mechanism of manganese exposure-induced dopaminergic toxicity. Brain Res. Bull. 76:361-67
213. Price CT, Langford JR, Liporace FA. 2012. Essential nutrients for bone health and a review of their availability in the average North American diet. Open Orthop. J. 6:143-49
214. Puri S, Bachert C, Fimmel CJ, Linstedt AD. 2002. Cycling of early Golgi proteins via the cell surface and endosomes upon lumenal pH disruption. Traffic 3:641-53
215. Quadri M, Federico A, Zhao T, Breedveld GJ, Battisti C, et al. 2012. Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease. Am. J. Hum. Genet. 90:467-77
216. Quamme GA. 2010. Molecular identification of ancient and modern mammalian magnesium transporters. Am. J. Physiol. Cell Physiol. 298:C407-29
217. Rabin O, Hegedus L, Bourre J, Smith QR. 1993. Rapid brain uptake of manganese(II) across the bloodbrain barrier. J. Neurochem. 61:509-17
218. Racette BA, Antenor JA, McGee-Minnich L, Moerlein SM, Videen TO, et al. 2005. [18F]FDOPA PET and clinical features in parkinsonism due to manganism. Mov. Disord. 20:492-96
219. Racette BA, Criswell SR, Lundin JI, Hobson A, Seixas N, et al. 2012. Increased risk of parkinsonism associated with welding exposure. Neurotoxicology 33:1356-61
220. Racette BA, McGee-Minnich L, Moerlein SM, Mink JW, Videen TO, Perimutter JS. 2001. Weldingrelated parkinsonism. Neurology 56:8-12
221. Ramirez A, Heimbach A, Grundemann J, Stiller B, Hampshire D, et al. 2006. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat. Genet. 38:1184-91
222. Ramonet D, Podhajska A, Stafa K, Sonnay S, Trancikova A, et al. 2012. PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity. Hum. Mol. Genet. 21:1725-43
223. Ramos P, Santos A, Pinto NR,Mendes R,Magalhaes T, Almeida A. 2014. Anatomical region differences and age-related changes in copper, zinc, and manganese levels in the human brain. Biol. Trace Element Res. 161:190-201
224. Reaney SH, Bench G, SmithDR. 2006. Brain accumulation and toxicity ofMn(II) andMn(III) exposures. Toxicol. Sci. 93:114-24
225. Reaney SH,Kwik-UribeCL, SmithDR. 2002. Manganese oxidation state and its implications for toxicity. Chem. Res. Toxicol. 15:1119-26
226. Reinhardt TA, Lippolis JD, Shull GE, Horst RL. 2004. Null mutation in the gene encoding plasma membrane Ca2+-ATPase isoform 2 impairs calcium transport into milk. J. Biol. Chem. 279:42369-73
227. Rentschler G, Covolo L, Haddad AA, Lucchini RG, Zoni S, Broberg K. 2012. ATP13A2 (PARK9) polymorphisms influence the neurotoxic effects of manganese. Neurotoxicology 33:697-702
228. Riccio A, Mattei C, Kelsell RE,Medhurst AD, Calver AR, et al. 2002. Cloning and functional expression of human short TRP7, a candidate protein for store-operated Ca2+ influx. J. Biol. Chem. 277:12302-9
229. Robinson SR. 2000. Neuronal expression of glutamine synthetase in Alzheimer s disease indicates a profound impairment of metabolic interactions with astrocytes. Neurochem. Int. 36:471-82
230. Robison G, Zakharova T, Fu S, JiangW, Fulper R, et al. 2012. X-ray fluorescence imaging: a new tool for studying manganese neurotoxicity. PLOS ONE 7:e48899
231. Robison G, Zakharova T, Fu S, Jiang W, Fulper R, et al. 2013. X-ray fluorescence imaging of the hippocampal formation after manganese exposure. Metallomics 5:1554-65
232. Rodriguez-Rodriguez E, Bermejo LM, Lopez-Sobaler AM, Ortega RM. 2011. An inadequate intake of manganese may favour insulin resistance in girls. Nutr. Hosp. 26:965-70
233. Roels H, Lauwerys R, Buchet JP, Genet P, Sarhan MJ, et al. 1987. Epidemiological survey among workers exposed to manganese: effects on lung, central nervous system, and some biological indices. Am. J. Ind. Med. 11:307-27
234. Rosas HD, Chen YI, Doros G, Salat DH, Chen NK, et al. 2012. Alterations in brain transition metals in Huntington disease: an evolving and intricate story. Arch. Neurol. 69:887-93
235. Roth J, Ponzoni S, AschnerM. 2013. Manganese homeostasis and transport. Met. Ions Life Sci. 12:169-201
236. Roth JA. 2006. Homeostatic and toxic mechanisms regulating manganese uptake, retention, and elimination. Biol. Res. 39:45-57
237. Roth JA, Ganapathy B, Ghio AJ. 2012. Manganese-induced toxicity in normal and human B lymphocyte cell lines containing a homozygous mutation in parkin. Toxicol. In Vitro 26:1143-49
238. Roth JA, Li Z, Sridhar S, Khoshbouei H. 2013. The effect of manganese on dopamine toxicity and dopamine transporter (DAT) in control and DAT transfected HEK cells. Neurotoxicology 35:121-28
239. Roth JA, Singleton S, Feng J, Garrick M, Paradkar PN. 2010. Parkin regulates metal transport via proteasomal degradation of the 1B isoforms of divalent metal transporter 1. J. Neurochem. 113:454-64
240. Sanders SS, Mui KK, Sutton LM, Hayden MR. 2014. Identification of binding sites in Huntingtin for the Huntingtin interacting proteins HIP14 and HIP14L. PLOS ONE 9:e90669
241. Santos D, Batoreu C, Mateus L, Marreilha Dos Santos AP, Aschner M. 2014. Manganese in human parenteral nutrition: considerations for toxicity and biomonitoring. Neurotoxicology 43:36-45
242. Sax HC, Talamini MA, Brackett K, Fischer JE. 1986. Hepatic steatosis in total parenteral nutrition: failure of fatty infiltration to correlate with abnormal serum hepatic enzyme levels. Surgery 100:697-704
243. Scheuhammer AM, Cherian MG. 1985. Binding ofmanganese in human and rat plasma. Biochim. Biophys. Acta 840:163-69
244. SchmidtK,Wolfe DM, Stiller B, Pearce DA. 2009. Cd2+,Mn2+,Ni2+ and Se2+ toxicity to Saccharomyces cerevisiae lacking YPK9p the orthologue of human ATP13A2. Biochem. Biophys. Res. Commun. 383:198-202
245. Schroeder HA, Balassa JJ, Tipton IH. 1996. Essential trace metals in man: manganese, a study in homeostasis. J. Chron. Dis. 19:545-71
246. Schulz JB, Matthews RT, Klockgether T, Dichgans J, Beal MF. 1997. The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases. Mol. Cell Biochem. 174:193-97
247. Scrutton MC, Utter MF. 1965. Pyruvate carboxylase: III. Some physical and chemical properties of the highly purified enzyme. J. Biol. Chem. 240:1-9
248. Scrutton MC, Utter MF, Mildvan AS. 1966. Pyruvate carboxylase: VI. The presence of tightly bound manganese. J. Biol. Chem. 241:3480-87
249. Seo YA, Li Y, Wessling-Resnick M. 2013. Iron depletion increases manganese uptake and potentiates apoptosis through ER stress. Neurotoxicology 38:67-73
250. Sepulveda MR, Marcos D, Berrocal M, Raeymaekers L, Mata AM, Wuytack F. 2008. Activity and localization of the secretory pathway Ca2+-ATPase isoform 1 (SPCA1) in different areas of the mouse brain during postnatal development. Mol. Cell Neurosci. 38:461-73
251. Sepulveda MR, Vanoevelen J, Raeymaekers L, Mata AM, Wuytack F. 2009. Silencing the SPCA1 (secretory pathway Ca2+-ATPase isoform 1) impairs Ca2+ homeostasis in the Golgi and disturbs neural polarity. J. Neurosci. 29:12174-82
252. SepulvedaMR, Wuytack F, Mata AM. 2012. High levels ofMn2+ inhibit secretory pathwayCa2+/Mn2+-ATPase (SPCA) activity and cause Golgi fragmentation in neurons and glia. J. Neurochem. 123:824-36
253. Seve M, Chimienti F,Devergnas S, Favier A. 2004. In silico identification and expression of SLC30 family genes: an expressed sequence tag data mining strategy for the characterization of zinc transporters tissue expression. BMC Genomics 5:32-40
254. Shaked I, Ben-Dror I, Vardimon L. 2002. Glutamine synthetase enhances the clearance of extracellular glutamate by the neural retina. J. Neurochem. 83:574-80
255. ShanX,Chi L, Ke Y, Luo C, Qian S, et al. 2007. Manganese superoxide dismutase protects mouse cortical neurons from chronic intermittent hypoxia-mediated oxidative damage. Neurobiol. Dis. 28:206-15
256. Sharma NK, Lebedeva M, Thomas T, Kovalenko OA, Stumpf JD, et al. 2014. Intrinsic mitochondrial DNA repair defects in ataxia telangiectasia. DNA Repair (Amst.) 13:22-31
257. Shi S, Zhao J, Yang L, NieX,Han J, et al. 2015.KHSRPparticipates in manganese-induced neurotoxicity in rat striatum and PC12 cells. J. Mol. Neurosci. 55:454-65
258. Sidoryk-Wegrzynowicz M, Lee E, Albrecht J, AschnerM. 2009. Manganese disrupts astrocyte glutamine transporter expression and function. J. Neurochem. 110:822-30
259. Siepler JK, Nishikawa RA, Diamantidis T, Okamoto R. 2003. Asymptomatic hypermanganesemia in long-term home parenteral nutrition patients. Nutr. Clin. Pract. 18:370-73
260. Singaraja RR, Hadano S, Metzler M, Givan S, Wellington CL, et al. 2002. HIP14, a novel ankyrin domain-containing protein, links huntingtin to intracellular trafficking and endocytosis. Hum. Mol. Genet. 11:2815-28
261. Singaraja RR, Huang K, Sanders SS, Milnerwood AJ, Hines R, et al. 2011. Altered palmitoylation and neuropathological deficits in mice lacking HIP14. Hum. Mol. Genet. 20:3899-909
262. Smith EA, Newland P, Bestwick KG, Ahmed N. 2012. Increased whole blood manganese concentrations observed in children with iron deficiency anaemia. J. Trace Elem. Med. Biol. 27:65-69
263. Spranger M, Schwab S, Desiderato S, Bonmann E, Krieger D, Fandrey J. 1998. Manganese augments nitric oxide synthesis in murine astrocytes: a new pathogenetic mechanism in manganism? Exp. Neurol. 149:277-83
264. Sriram K, Jefferson AM, Lin GX, Afshari A, Zeidler-Erdely PC, et al. 2014. Neurotoxicity following acute inhalation of aerosols generated during resistance spot weld-bonding of carbon steel. Inhal. Toxicol. 26:720-32
265. Sriram K, Lin GX, Jefferson AM, Roberts JR, Wirth O, et al. 2010. Mitochondrial dysfunction and loss of Parkinson s disease-linked proteins contribute to neurotoxicity of manganese-containing welding fumes. FASEB J. 24:4989-5002
266. StansfieldKH, BichellTJ, Bowman AB,Guilarte TR. 2014.BDNFand huntingtin protein modifications by manganese: implications for striatal medium spiny neuron pathology in manganese neurotoxicity. J. Neurochem. 131:655-66
267. Stef DS, Gergen I. 2012. Effect of mineral-enriched diet and medicinal herbs on Fe, Mn, Zn, and Cu uptake in chicken. Chem. Cent. J. 6:19
268. Stephenson AP, Schneider JA, Nelson BC, Atha DH, Jain A, et al. 2013. Manganese-induced oxidative DNA damage in neuronal SH-SY5Y cells: attenuation of thymine base lesions by glutathione and Nacetylcysteine. Toxicol. Lett. 218:299-307
269. Stredrick DL, Stokes AH, Worst TJ, Freeman WM, Johnson EA, et al. 2004. Manganese-induced cytotoxicity in dopamine-producing cells. Neurotoxicology 25:543-53
270. Subhash MN, Padmashree TS. 1990. Regional distribution of dopamine beta-hydroxylase and monoamine oxidase in the brains of rats exposed to manganese. Food Chem. Toxicol. 28:567-70
271. SuttonLM, Sanders SS, Butland SL, Singaraja RR, Franciosi S, et al. 2013. Hip14l-deficient mice develop neuropathological and behavioural features of Huntington disease. Hum. Mol. Genet. 22:452-65
272. Suwalsky M, Villena F, Sotomayor CP. 2010. Mn2+ exerts stronger structural effects than the Mn-citrate complex on the human erythrocyte membrane and molecular models. J. Inorg. Biochem. 104:55-61
273. Takeda AJ, Sawashita J, Okada S. 1998. Manganese concentration in rat brain: manganese transport from the peripheral tissues. Neurosci. Lett. 242:45-48
274. Tan J, Zhang T, Jiang L, Chi J, Hu D, et al. 2011. Regulation of intracellular manganese homeostasis by Kufor-Rakeb syndrome-associated ATP13A2 protein. J. Biol. Chem. 286:29654-62
275. Tewari R, Jarvela T, Linstedt AD. 2014. Manganese induces oligomerization to promote downregulation of the intracellular trafficking receptor used by Shiga toxin. Mol. Biol. Cell 25:3049-58
276. Tidball AM, Bryan MR,UhouseMA, Kumar KK, Aboud AA, et al. 2014. A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington s disease. Hum. Mol. Genet. 24:1929-44
277. Ton VK, Mandal D, Vahadji C, Rao R. 2002. Functional expression in yeast of the human secretory pathway Ca2+, Mn2+-ATPase defective in Hailey-Hailey disease. J. Biol. Chem. 277:6422-27
278. Trujillo KM, Yuan SSF, Lee EY-HP, Sung P. 1998. Nuclease activities in a complex of human recombination and DNA repair factors Rad50, Mre11, and p95. J. Biol. Chem. 273:21447-50
279. TsunemiT,KraincD. 2014. Zn2+ dyshomeostasis caused by loss ofATP13A2/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation. Hum. Mol. Genet. 23:2791-801
280. Tuschl K, Clayton PT, Gospe SM Jr, Gulab S, Ibrahim S, et al. 2012. Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man. Am. J. Hum. Genet. 90:457-66
281. Ugolino J, Fang S, Kubisch C, Monteiro MJ. 2011. Mutant Atp13a2 proteins involved in parkinsonism are degraded by ER-associated degradation and sensitize cells to ER-stress induced cell death. Hum. Mol. Genet. 20:3565-77
282. van Veen S, Sorensen DM, Holemans T, Holen HW, Palmgren MG, Vangheluwe P. 2014. Cellular function and pathological role of ATP13A2 and related P-type transport ATPases in Parkinson s disease and other neurological disorders. Front. Mol. Neurosci. 7:48
283. Vanoevelen J, Dode L, Van Baelen K, Fairclough RJ, Missiaen L, et al. 2005. The secretory pathway Ca2+/Mn2+-ATPase 2 is a Golgi-localized pump with high affinity for Ca2+ ions. J. Biol. Chem. 280:22800-8
284. Varro A, Negretti N, Hester SB, Eisner DA. 1993. An estimate of the calcium content of the sarcoplasmic reticulum in rat ventricular myocytes. Pflugers Arch. 423:158-60
285. Waghorn B, Schumacher A, Liu J, Jacobs S, Baba A, et al. 2011. Indirectly probing Ca2+ handling alterations following myocardial infarction in a murine model using T1-mapping manganese-enhanced magnetic resonance imaging. Magn. Reson. Med. 65:239-49
286. Waghorn B, Yang Y, Baba A, Matsuda T, Schumacher A, et al. 2009. Assessing manganese efflux using SEA0400 and cardiac T1-mapping manganese-enhanced MRI in a murine model.NMR Biomed. 22:874-81
287. Wang CY, Jenkitkasemwong S, Duarte S, Sparkman BK, Shawki A, et al. 2012. ZIP8 is an iron and zinc transporter whose cell-surface expression is up-regulated by cellular iron loading. J. Biol. Chem. 287:34032-43
288. Wang R, Zhu X. 2003. Subtoxic concentration of manganese synergistically potentiates 1-methyl-4-phenylpyridinium-induced neurotoxicity in PC12 cells. Brain Res. 961:131-38
289. Wang X, Miller DS, Zheng W. 2008. Intracellular localization and subsequent redistribution of metal transporters in a rat choroid plexus model following exposure to manganese or iron. Toxicol. Appl. Pharmacol. 230:167-74
290. Wang XS, Ong WY, Connor JR. 2001. A light and electron microscopic study of the iron transporter protein DMT-1 in the monkey cerebral neocortex and hippocampus. J. Neurocytol. 30:353-60
291. Wegrzynowicz M, Holt HK, Friedman DB, Bowman AB. 2012. Changes in the striatal proteome of YAC128Q mice exhibit gene-environment interactions between mutant Huntingtin and manganese. J. Proteome Res. 11:1118-32
292. Wei Y, Chen J, Rosas G, Tompkins DA, Holt PA, Rao R. 2000. Phenotypic screening of mutations in Pmr1, the yeast secretory pathway Ca2+/Mn2+-ATPase, reveals residues critical for ion selectivity and transport. J. Biol. Chem. 275:23927-32
293. Williams BB, Kwakye GF,Wegrzynowicz M, Li D, AschnerM, et al. 2010. Altered manganese homeostasis and manganese toxicity in a Huntington s disease striatal cell model are not explained by defects in the iron transport system. Toxicol. Sci. 117:169-79
294. Williams BB, Li D, Wegrzynowicz M, Vadodaria BK, Anderson JG, et al. 2010. Disease-toxicant screen reveals a neuroprotective interaction between Huntington s disease and manganese exposure. J. Neurochem. 112:227-37
295. Wilson DC, Tubman TR, Halliday HL, McMaster D. 1992. Plasma manganese levels in the very low birth weight infant are high in early life. Biol. Neonate 61:42-46
296. Wootton LL, Argent CC, Wheatley M, Michelangeli F. 2004. The expression, activity and localisation of the secretory pathway Ca2+-ATPase (SPCA1) in different mammalian tissues. Biochim. Biophys. Acta 1664:189-97
297. Wozniak-Celmer E, Oldziej S, Ciarkowski J. 2001. Theoretical models of catalytic domains of protein phosphatases 1 and 2A with Zn2+ and Mn2+ metal dications and putative bioligands in their catalytic centers. Acta Biochim. Pol. 48:35-52
298. Wuytack F, Raeymaekers L, Missiaen L. 2002. Molecular physiology of the SERCA and SPCA pumps. Cell Calcium 32:279-305
299. XiangM,MohamalawariD,Rao R. 2005. A novel isoform of the secretory pathway Ca2+,Mn2+-ATPase, hSPCA2, has unusual properties and is expressed in the brain. J. Biol. Chem. 280:11608-14
300. Xiao L, Gong LL, Yuan D, Deng M, Zeng XM, et al. 2010. Protein phosphatase-1 regulates Akt1 signal transduction pathway to control gene expression, cell survival and differentiation. Cell Death Differ. 17:1448-62
301. Xu SZ, Zeng F, Boulay G, Grimm C, Harteneck C, Beech DJ. 2005. Block of TRPC5 channels by 2-aminoethoxydiphenyl borate: a differential, extracellular and voltage-dependent effect. Br. J. Pharmacol. 145:405-14
302. Yanai A, Huang K, Kang R, Singaraja RR, Arstikaitis P, et al. 2006. Palmitoylation of huntingtin by HIP14 is essential for its trafficking and function. Nat. Neurosci. 9:824-31
303. Yang J, Gonon AT, Sjoquist PO, Lundberg JO, Pernow J. 2013. Arginase regulates red blood cell nitric oxide synthase and export of cardioprotective nitric oxide bioactivity. PNAS 110:15049-54
304. Yin Z, Jiang H, Lee ES, Ni M, Erikson KM, et al. 2010. Ferroportin is a manganese-responsive protein that decreases manganese cytotoxicity and accumulation. J. Neurochem. 112:1190-98
305. Yokel RA. 2009. Manganese flux across the blood-brain barrier. Neuromol. Med. 11:297-310
306. Yokel RA, Crossgrove JS, Bukaveckas BL. 2003. Manganese distribution across the blood-brain barrier. II. Manganese efflux from the brain does not appear to be carrier mediated. Neurotoxicology 24:15-22
307. Yu H, Iyer RK, Kern RM, Rodriguez WI, Grody WW, Cederbaum SD. 2001. Expression of arginase isozymes in mouse brain. J. Neurosci. Res. 66:406-22
308. Zeron HM, Rodriguez MR, Montes S, Castaneda CR. 2011. Blood manganese levels in patients with hepatic encephalopathy. J. Trace Elements Med. Biol. 25:225-29
309. Zhang P, Lokuta KM, Turner DE, Liu B. 2010. Synergistic dopaminergic neurotoxicity of manganese and lipopolysaccharide: differential involvement of microglia and astroglia. J. Neurochem. 112:434-43
310. Zhang S, Fu J, Zhou Z. 2005. Changes in the brain mitochondrial proteome of male Sprague-Dawley rats treated with manganese chloride. Toxicol. Appl. Pharmacol. 202:13-17
311. Zidenberg-Cherr S, Keen CL, L onnerdal B, Hurley LS. 1983. Superoxide dismutase activity and lipid peroxidation in the rat: developmental correlations affected by manganese deficiency. J. Nutr. 113:2498-504
312. Zlotkin SH, Atkinson S, Lockitch G. 1995. Trace elements in nutrition for premature infants. Clin. Perinatol. 22:223-40
313. Zou J, Wang YX, Dou FF, Lu HZ,Ma ZW, et al. 2010. Glutamine synthetase down-regulation reduces astrocyte protection against glutamate excitotoxicity to neurons. Neurochem. Int. 56:577-84
314. Zou JY, Crews FT. 2005. TNFαpotentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NFκB inhibition. Brain Res. 1034:11-24